🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
37854
CAS Number:
143491-57-0
Emtricitabine
Purity:
≥ 98% (Assay by titration , HPLC)
Temperature Sensitive
Documents
$51.18 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Emtricitabine is a potent nucleoside reverse transcriptase inhibitor (NRTI) widely utilized in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. This compound is recognized for its ability to inhibit viral replication, making it a crucial component of antiretroviral therapy regimens. Emtricitabine's unique structure, featuring a fluorine atom and an oxathiolane ring, enhances its efficacy and bioavailability, allowing for once-daily dosing that improves patient adherence to treatment.

In addition to its primary applications in HIV and HBV therapies, Emtricitabine is also being explored for its potential in pre-exposure prophylaxis (PrEP) to prevent HIV transmission in high-risk populations. Its favorable safety profile and minimal side effects further establish it as a preferred choice among healthcare providers. Researchers and industry professionals value Emtricitabine not only for its therapeutic benefits but also for its role in advancing public health initiatives aimed at controlling viral infections.

CAS Number
143491-57-0
Purity
≥ 98% (Assay by titration , HPLC)
Molecular Formula
C8H10FN3O3S
Molecular Weight
247.24
MDL Number
MFCD00870151
PubChem ID
9837769
Melting Point
153 - 157 °C
Appearance
White to light yellow powder to crystal
Optical Rotation
[a]20D = -137 to -143 ° (C=0.25 in MeOH)
Conditions
Store at -10 °C
General Information
CAS Number
143491-57-0
Purity
≥ 98% (Assay by titration , HPLC)
Molecular Formula
C8H10FN3O3S
Molecular Weight
247.24
MDL Number
MFCD00870151
PubChem ID
9837769
Melting Point
153 - 157 °C
Appearance
White to light yellow powder to crystal
Optical Rotation
[a]20D = -137 to -143 ° (C=0.25 in MeOH)
Conditions
Store at -10 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Emtricitabine is widely utilized in research focused on

  • Antiretroviral Therapy: Primarily used in the treatment of HIV, Emtricitabine is a key component in combination therapies, helping to reduce viral load and improve immune function in patients.
  • Pre-Exposure Prophylaxis (PrEP): This compound is effective in preventing HIV infection in high-risk populations, offering a proactive approach to sexual health and safety.
  • Research on Drug Resistance: Emtricitabine is often studied to understand and combat drug resistance in HIV, providing insights that help in developing more effective treatments.
  • Pharmaceutical Development: Used as a benchmark in the development of new antiviral drugs, Emtricitabine serves as a model for creating compounds with improved efficacy and safety profiles.
  • Combination Therapies: Its compatibility with other antiretroviral agents makes it a valuable asset in multi-drug regimens, enhancing treatment outcomes for patients with complex needs.

Citations